Pfizer (PFE) Tops Q3 EPS by 13c, Raises FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.45 -1.25%
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.26 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.94-$3.00, versus the consensus of $2.82. Pfizer sees FY2019 revenue of $51.2-52.2 billion, versus the consensus of $51.32 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Morgan Stanley Downgrades Infineon Technologies (IFX:GY) (IFNNY) to Equalweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
